Tag: clinical-stage company
August 26, 2018
5 Top Weekly NASDAQ Biotech Stocks: Bellerophon Leads the Pack
Bellerophon Therapeutics, Chiasma, BioLife Solutions, Cerecor and MiMedx Group were last week's top gainers on the NASDAQ Biotechnology Index. August 12, 2018
5 Top Weekly NASDAQ Biotech Stocks: Vericel Takes Top Spot
Vericel, AcelRx, Tetraphase Pharmaceuticals, KalVista and Infinity Pharmaceuticals were last week's top gainers on the NASDAQ Biotechnology Index. July 29, 2018
5 Top Weekly NASDAQ Biotech Stocks: resTORbio Leads the Pack
resTORbio, ADMA Biologics, Misonix, Novus Therapeutics and Innovate Biopharmaceuticals were last week's top gainers on the NASDAQ Biotechnology Index. July 15, 2018
5 Top Weekly NASDAQ Biotech Stocks: Arbutus on Top
Adamis Pharmaceutical, Juniper Pharmaceuticals, Anavex Life Sciences, Arbutus BioPharma and Soleno Therapeutics were last week's top gainers on the NASDAQ... June 10, 2018
5 Top Weekly NASDAQ Biotech Stocks: MEI Pharma on Top
MEI Pharma, Anavex Life Sciences, Trillium Therapeutics, Celldex Therapeutics and Ophthotech were last week's top gainers on the NASDAQ Biotechnology... May 13, 2018
5 Top Weekly NASDAQ Biotech Stocks: Helius Up 43.19 Percent
Helius Medical Technologies, vTv Therapeutics, Second Sight Medical Products, Depomed and Senomyx were last week's top gainers on the NASDAQ. May 7, 2018
Auris Medical Receives Positive Scientific Advice from EMA on Development Plan and Regulatory Pathway for AM-111
Auris Medical (NASDAQ:EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in neurotology, announced today... April 29, 2018
5 Top Weekly NASDAQ Biotech Stocks: Eleven Biotherapeutics Up 45 Percent
Eleven Biotherapeutics, EyePoint Pharmaceuticals, Avid Bioservices, Cerecor and Celldex were last week's top gainers on the NASDAQ. April 20, 2018
Clementia Initiates Phase 2 MO-Ped Trial for Palovarotene in Patients with Multiple Osteochondromas
Clementia Pharmaceuticals (NASDAQ:CMTA), a clinical-stage company innovating new treatments for people with ultra-rare bone disorders and other diseases, today announced the... April 10, 2018